Immune supplementation and immune modulation with intravenous immunoglobulin - 18/08/11
Doi : 10.1016/j.jaci.2005.07.021
Bruce D. Mazer, MD, Salem Al-Tamemi, MD, Joyce W. Yu, MD, Qutayba Hamid, MD, PhD ⁎ 
: Editors
: Editors From Meakins Christie Laboratories, McGill University and the McGill University Heath Center-Montreal Children’s Hospital
Reprint requests: Qutayba Hamid, MD, PhD, McGill University, Meakins-Christie Laboratory, 3626 St Urbain St, Montreal H2X 2P2, Canada.| Editor’s note: This feature, Images in allergy and immunology, is designed to highlight current concepts of the immunopathology of allergic diseases and other common immunologically mediated diseases. The presentation will appear as sets of images that involve cross-pathology, histopathology, and molecular pathology and will cover a range of topics of interest to allergists and immunologists. |
|
| Disclosure of potential conflict of interest: Dr Mazer receives research grant support from Bayer, Inc. All other authors—nothing to disclose. |
© 2005
American Academy of Allergy, Asthma and Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 116 - N° 4
P. 941-944 - octobre 2005 Retour au numéro
Article précédent
- Charles A. Janeway and Fred S. Rosen: The discovery of gamma globulin therapy and primary immunodeficiency diseases at Boston Children's Hospital
- Raif S. Geha
- Beyond Our Pages
- Burton Zweiman, Marc E. Rothenberg
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?